Compare RDWR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDWR | PRCT |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2000 | 2021 |
| Metric | RDWR | PRCT |
|---|---|---|
| Price | $28.00 | $20.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $32.50 | ★ $35.44 |
| AVG Volume (30 Days) | 152.2K | ★ 930.8K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $10.65 | $31.34 |
| Revenue Next Year | $8.62 | $24.52 |
| P/E Ratio | $59.76 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $21.68 | $16.67 |
| 52 Week High | $32.79 | $40.10 |
| Indicator | RDWR | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 44.46 |
| Support Level | $26.61 | $19.87 |
| Resistance Level | $29.16 | $29.27 |
| Average True Range (ATR) | 0.86 | 1.04 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 28.85 | 4.55 |
Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.